pyridostigmine bromide has been researched along with Adrenal Cortex Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karavitaki, N; Stylianidou, C; Thalassinos, NC; Tsagarakis, S; Tzanela, M | 1 |
| Karavitaki, N; Stylianidou, Ch; Thalassinos, NC; Tsagarakis, S; Tzanela, M; Zianni, D | 1 |
2 other study(ies) available for pyridostigmine bromide and Adrenal Cortex Cancer
| Article | Year |
|---|---|
Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome.
Topics: ACTH Syndrome, Ectopic; Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adult; Aged; Cholinesterase Inhibitors; Cushing Syndrome; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Male; Middle Aged; Pyridostigmine Bromide; Statistics, Nonparametric | 2004 |
Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aged; Analysis of Variance; Cholinesterase Inhibitors; Dexamethasone; Female; Glucocorticoids; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hydrocortisone; Incidental Findings; Male; Middle Aged; Predictive Value of Tests; Pyridostigmine Bromide; Statistics, Nonparametric | 2005 |